These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32197982)

  • 21. Co-delivery of PDTC and doxorubicin by multifunctional micellar nanoparticles to achieve active targeted drug delivery and overcome multidrug resistance.
    Fan L; Li F; Zhang H; Wang Y; Cheng C; Li X; Gu CH; Yang Q; Wu H; Zhang S
    Biomaterials; 2010 Jul; 31(21):5634-42. PubMed ID: 20430433
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fabrication of biocompatible magnetic maltose/MIL-88 metal-organic frameworks decorated with folic acid-chitosan for targeted and pH-responsive controlled release of doxorubicin.
    Karimi S; Namazi H
    Int J Pharm; 2023 Mar; 634():122675. PubMed ID: 36736967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ligand-directed stearic acid grafted chitosan micelles to increase therapeutic efficacy in hepatic cancer.
    Yang Y; Yuan SX; Zhao LH; Wang C; Ni JS; Wang ZG; Lin C; Wu MC; Zhou WP
    Mol Pharm; 2015 Feb; 12(2):644-52. PubMed ID: 25495890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Theoretical Investigation of Chitosan-Assisted Controlled Release of Digestive System Antitumor Drug Fluorouracil.
    Lu Y; Liang L; Shen G; Yao W; Zhang C; Huang D; Xuan Z; Li J; Liu J
    J Pharm Sci; 2022 Jul; 111(7):2049-2055. PubMed ID: 35122829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of molecular weight on the oleoyl-chitosan nanoparticles as carriers for doxorubicin.
    Zhang J; Chen XG; Sun GZ; Huang L; Cheng XJ
    Colloids Surf B Biointerfaces; 2010 Jun; 77(2):125-30. PubMed ID: 20172698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chlorin e6 decorated doxorubicin encapsulated chitosan nanoparticles for photo-controlled cancer drug delivery.
    Bhatta A; Krishnamoorthy G; Marimuthu N; Dihingia A; Manna P; Biswal HT; Das M; Krishnamoorthy G
    Int J Biol Macromol; 2019 Sep; 136():951-961. PubMed ID: 31226376
    [TBL] [Abstract][Full Text] [Related]  

  • 27. pH-sensitive amphiphilic chitosan-quercetin conjugate for intracellular delivery of doxorubicin enhancement.
    Mu Y; Wu G; Su C; Dong Y; Zhang K; Li J; Sun X; Li Y; Chen X; Feng C
    Carbohydr Polym; 2019 Nov; 223():115072. PubMed ID: 31427010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemosensitizing indomethacin-conjugated chitosan oligosaccharide nanoparticles for tumor-targeted drug delivery.
    Lee JY; Termsarasab U; Lee MY; Kim DH; Lee SY; Kim JS; Cho HJ; Kim DD
    Acta Biomater; 2017 Jul; 57():262-273. PubMed ID: 28483700
    [TBL] [Abstract][Full Text] [Related]  

  • 29. pH-responsive glycol chitosan-cross-linked carboxymethyl-β-cyclodextrin nanoparticles for controlled release of anticancer drugs.
    Wang Y; Qin F; Tan H; Zhang Y; Jiang M; Lu M; Yao X
    Int J Nanomedicine; 2015; 10():7359-69. PubMed ID: 26677325
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biodegradable PLGA implants containing doxorubicin-loaded chitosan nanoparticles for treatment of breast tumor-bearing mice.
    Kefayat A; Vaezifar S
    Int J Biol Macromol; 2019 Sep; 136():48-56. PubMed ID: 31195043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chitosan based nanogels stepwise response to intracellular delivery kinetics for enhanced delivery of doxorubicin.
    Zuo Y; Kong M; Mu Y; Feng C; Chen X
    Int J Biol Macromol; 2017 Nov; 104(Pt A):157-164. PubMed ID: 28600203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycol Chitosan-Docosahexaenoic Acid Liposomes for Drug Delivery: Synergistic Effect of Doxorubicin-Rapamycin in Drug-Resistant Breast Cancer.
    Kim MW; Niidome T; Lee R
    Mar Drugs; 2019 Oct; 17(10):. PubMed ID: 31614820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chitosan/o-carboxymethyl chitosan nanoparticles for efficient and safe oral anticancer drug delivery: in vitro and in vivo evaluation.
    Feng C; Wang Z; Jiang C; Kong M; Zhou X; Li Y; Cheng X; Chen X
    Int J Pharm; 2013 Nov; 457(1):158-67. PubMed ID: 24029170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro and in vivo study of Gal-OS self-assembled nanoparticles for liver-targeting delivery of doxorubicin.
    Guo H; Zhang D; Li T; Li C; Guo Y; Liu G; Hao L; Shen J; Qi L; Liu X; Luan J; Zhang Q
    J Pharm Sci; 2014 Mar; 103(3):987-93. PubMed ID: 24549734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. pH-sensitive magnetic drug delivery system via layer-by-layer self-assembly of CS/PEG and its controlled release of DOX.
    Wu J; Wang X; Zhu B; He Q; Ren F; Tong F; Jiang W; He X
    J Biomater Sci Polym Ed; 2020 Jun; 31(8):1057-1070. PubMed ID: 32175824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel delivery system of doxorubicin with high load and pH-responsive release from the nanoparticles of poly (α,β-aspartic acid) derivative.
    Wang X; Wu G; Lu C; Zhao W; Wang Y; Fan Y; Gao H; Ma J
    Eur J Pharm Sci; 2012 Aug; 47(1):256-64. PubMed ID: 22522116
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Doxorubicin and siRNA Codelivery via Chitosan-Coated pH-Responsive Mixed Micellar Polyplexes for Enhanced Cancer Therapy in Multidrug-Resistant Tumors.
    Butt AM; Amin MC; Katas H; Abdul Murad NA; Jamal R; Kesharwani P
    Mol Pharm; 2016 Dec; 13(12):4179-4190. PubMed ID: 27934479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterizing poly(epsilon-caprolactone)-b-chitooligosaccharide-b-poly(ethylene glycol) (PCP) copolymer micelles for doxorubicin (DOX) delivery: effects of crosslinked of amine groups.
    Chung TW; Liu DZ; Hsieh JH; Fan XC; Yang JD; Chen JH
    J Nanosci Nanotechnol; 2006; 6(9-10):2902-11. PubMed ID: 17048497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. pH-controlled nucleolin targeted release of dual drug from chitosan-gold based aptamer functionalized nano drug delivery system for improved glioblastoma treatment.
    Sathiyaseelan A; Saravanakumar K; Mariadoss AVA; Wang MH
    Carbohydr Polym; 2021 Jun; 262():117907. PubMed ID: 33838795
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Co-delivery of doxorubicin and interleukin-2 via chitosan based nanoparticles for enhanced antitumor efficacy.
    Wu J; Tang C; Yin C
    Acta Biomater; 2017 Jan; 47():81-90. PubMed ID: 27729232
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.